Human medicines European public assessment report (EPAR): Tygacil, tigecycline, Date of authorisation: 24/04/2006, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Tygacil, tigecycline, Date of authorisation: 24/04/2006, Revision: 36, Status: Authorised

Human medicines European public assessment report (EPAR): Amsparity, adalimumab, Date of authorisation: 13/02/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): Amsparity, adalimumab, Date of authorisation: 13/02/2020, Revision: 10, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.